125 related articles for article (PubMed ID: 11475557)
21. [Eotaxin in induced sputum in patients with asthma and chronic bronchitis: relationship with airway inflammation].
Fu J; Chen P; Xiang X
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jan; 25(1):29-32. PubMed ID: 11953096
[TBL] [Abstract][Full Text] [Related]
22. [Changes of leukotriene B4 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and the effects of theophylline].
Ding YL; Yao WZ; Liu Z; Wang YZ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):441-4. PubMed ID: 16115390
[TBL] [Abstract][Full Text] [Related]
23. A rapid chemokine response of macrophage inflammatory protein (MIP)-1α, MIP-1β and the regulated on activation, normal T expressed and secreted chemokine is associated with a sustained virological response in the treatment of chronic hepatitis C.
Florholmen J; Kristiansen MG; Steigen SE; Sørbye SW; Paulssen EJ; Kvamme JM; Konopski Z; Gutteberg T; Goll R
Clin Microbiol Infect; 2011 Feb; 17(2):204-9. PubMed ID: 20219081
[TBL] [Abstract][Full Text] [Related]
24. Chemokine levels in human liver homogenates: associations between GRO alpha and histopathological evidence of alcoholic hepatitis.
Maltby J; Wright S; Bird G; Sheron N
Hepatology; 1996 Nov; 24(5):1156-60. PubMed ID: 8903391
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-18 in induced sputum: association with lung function in chronic obstructive pulmonary disease.
Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
Respir Med; 2009 Jul; 103(7):1056-62. PubMed ID: 19208460
[TBL] [Abstract][Full Text] [Related]
26. Influence of human T lymphotrophic virus type I on diffuse pan-bronchiolitis.
Yamamoto M; Matsuyama W; Oonakahara K; Watanabe M; Higashimoto I; Kawabata M; Osame M; Arimura K
Clin Exp Immunol; 2004 Jun; 136(3):513-20. PubMed ID: 15147354
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy of a complementary antiinflammatory treatment with erespal in chronic obstructive and nonobstructive bronchitis].
Volkova LI; Budkova AA; Filonova NN; Khristoliubova EI; Kutuzova EB; Koroleva NV; Radzivil TT; Aminova ZR; Chuchalin AG
Ter Arkh; 2004; 76(8):51-6. PubMed ID: 15471398
[TBL] [Abstract][Full Text] [Related]
28. [Serum and cerebrospinal fluid concentration of inflammatory proteins MIP-1-alpha and MIP-1-beta and of interleukin 8 in the course of borreliosis].
Grygorczuk S; Pancewicz S; Kondrusik M; Swierzbińska R; Zajkowska J; Hermanowska-Szpakowicz T
Neurol Neurochir Pol; 2003; 37(1):73-87. PubMed ID: 12910831
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease.
Demedts IK; Bracke KR; Van Pottelberge G; Testelmans D; Verleden GM; Vermassen FE; Joos GF; Brusselle GG
Am J Respir Crit Care Med; 2007 May; 175(10):998-1005. PubMed ID: 17332482
[TBL] [Abstract][Full Text] [Related]
30. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes.
Uguccioni M; D'Apuzzo M; Loetscher M; Dewald B; Baggiolini M
Eur J Immunol; 1995 Jan; 25(1):64-8. PubMed ID: 7531149
[TBL] [Abstract][Full Text] [Related]
31. [Expression and significance of beta(2)-adrenoreceptor in inflammatory cells of patients with chronic obstructive pulmonary disease].
Zhu WJ; He B; Xu M
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2099-102. PubMed ID: 19080468
[TBL] [Abstract][Full Text] [Related]
32. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
Xiao W; Tong WL; Ma DD
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
[TBL] [Abstract][Full Text] [Related]
33. Innate immunity proteins in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.
Tsoumakidou M; Bouloukaki I; Thimaki K; Tzanakis N; Siafakas NM
Exp Lung Res; 2010 Aug; 36(6):373-80. PubMed ID: 20653472
[TBL] [Abstract][Full Text] [Related]
34. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease.
Bresser P; Out TA; van Alphen L; Jansen HM; Lutter R
Am J Respir Crit Care Med; 2000 Sep; 162(3 Pt 1):947-52. PubMed ID: 10988111
[TBL] [Abstract][Full Text] [Related]
35. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
[TBL] [Abstract][Full Text] [Related]
36. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies.
Snoeck-Stroband JB; Lapperre TS; Gosman MM; Boezen HM; Timens W; ten Hacken NH; Sont JK; Sterk PJ; Hiemstra PS;
Eur Respir J; 2008 Jan; 31(1):70-7. PubMed ID: 17804442
[TBL] [Abstract][Full Text] [Related]
37. Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis.
Chen S; Liu Z; Chen H; Zhou H; Wang J; Li L
Chin Med J (Engl); 2002 Sep; 115(9):1301-7. PubMed ID: 12411099
[TBL] [Abstract][Full Text] [Related]
38. Beta-chemokine function in experimental lung ischemia-reperfusion injury.
Krishnadasan B; Farivar AS; Naidu BV; Woolley SM; Byrne K; Fraga CH; Mulligan MS
Ann Thorac Surg; 2004 Mar; 77(3):1056-62. PubMed ID: 14992926
[TBL] [Abstract][Full Text] [Related]
39. Changes in circulating thrombomodulin levels with exercise in patients with chronic obstructive pulmonary disease.
Kanazawa H; Asai K; Nomura S
Respirology; 2007 Sep; 12(5):670-4. PubMed ID: 17875054
[TBL] [Abstract][Full Text] [Related]
40. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
